TIMP2 and cholangiocarcinoma: Prakobwong et al. reported a significantly increase in type I collagen, hydroxyproline (HYP), metrixmetalloproteinase-7 (MMP-7) and the tissue inhibitor of MMP-2 (TIMP-2) levels in CCA plasma compared to healthy and benign biliary disease [32].